MNTA - Momenta Pharmaceuticals Inc.
Previous close
52.48
0 0%
Share volume: 0
Last Updated: Wed 30 Sep 2020 06:00:00 AM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
$52.48
0.00
0.00%
Summary score
35%
Profitability
50%
Dept financing
9%
Liquidity
17%
Performance
30%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.55%
Return on assets
-9.1%
Return on sales
0%
Return on invested capital
-54.81%
Total debt ratio
25.21%
Debt ratio change over timeo
-1.1%
Current Ratio
6.45%
Quick Ratio
0%
Cash Position Ratio
2.44%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.72%
Return on assets
-11.86%
Return on sales
0%
Return on invested capital
517.6%
Total debt ratio
26.58%
Debt ratio change over timeo
-1.16%
Current Ratio
6.1%
Quick Ratio
0%
Cash Position Ratio
2.86%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.43%
Return on assets
-11%
Return on sales
0%
Return on invested capital
980.27%
Total debt ratio
24.45%
Debt ratio change over time
-0.97%
Current Ratio
6.38%
Quick Ratio
0%
Cash Position Ratio
2.66%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-88.26%
Return on assets
-91.79%
Return on sales
0%
Return on invested capital
-37.76%
Total debt ratio
-110.44%
Debt ratio change over time
-1.1%
Current Ratio
-2.46%
Quick Ratio
0%
Cash Position Ratio
-2.4%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MNTA | IMMU | ONCE | THOR |
|---|---|---|---|---|
| Return on equity | -11.55% | -38.69% | -12.25% | 80.18% |
| Return on assets | -9.1% | -18.71% | -9.49% | -16.7% |
| Return on sales | 0% | -4785.64% | -349.39% | 0% |
| Return on invested capital | -54.81% | 328.34% | -117.39% | 503.42% |
| Profitability | 50% | 16% | 0% | 50% |
| Total debt ratio | 25.21% | 115.92% | 26.21% | 26.3% |
| Debt ratio change over time | -1.1% | -0.17% | -1.45% | -0.66% |
| Dept financing | 5% | 50% | 6% | 6% |
| Current Ratio | 6.1% | 9.16% | 4.67% | 18.87% |
| Quick Ratio | 0% | 12.58% | 4.35% | 0% |
| Cash Position Ratio | 2.86% | 8.72% | 2.07% | 2.22% |
| Liquididy | 20% | 49% | 51% | 48% |
| Short-term ratios | MNTA | IMMU | ONCE | THOR |
|---|---|---|---|---|
| Return on equity | -14.72% | -121.38% | -19.25% | -8.04% |
| Return on assets | -11.86% | -13.34% | -9.76% | -8.05% |
| Return on sales | 0% | -264.08% | -305.87% | 0% |
| Return on invested capital | 517.6% | 262.79% | -49.24% | 520.72% |
| Profitability | 50% | 13% | 0% | 75% |
| Total debt ratio | 26.58% | 66.94% | 50.82% | 7.15% |
| Debt ratio change over time | -1.16% | -0.82% | -2.24% | -0.98% |
| Dept financing | 10% | 50% | 19% | 3% |
| Current Ratio | 6.1% | 9.16% | 4.67% | 18.87% |
| Quick Ratio | 0% | 12.58% | 4.35% | 0% |
| Cash Position Ratio | 2.86% | 8.72% | 2.07% | 2.22% |
| Liquididy | 16% | 62% | 21% | 31% |